Assessing vitamin D status: Pitfalls for the unwary

Molecular Nutrition and Food Research

Volumn 54, Issue 8, 2010, Pages 1062-1071

  Lai, Jeffrey K C ^a   Lucas, Robyn M ^a   Clements, Mark S ^a   Harrison, Simone L ^b   Banks, Emily ^a  

^a The Australian National University   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

1,25(OH)2D; 25(OH)D; Precision; Vitamin D assay; Vitamin D deficiency

Indexed keywords

25 HYDROXYERGOCALCIFEROL; CALCIFEDIOL; VITAMIN D;

BLOOD; GENETICS; HUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PHYSIOLOGY; REPRODUCIBILITY; REVIEW; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D 2; CALCIFEDIOL; HUMANS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; REPRODUCIBILITY OF RESULTS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77954834215     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900468     Document Type: Review

References (96)

1. Holick, M. F., Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 2004, 80, 1678S-1688S.
2. Walters, M. R., Newly identified actions of the vitamin-D endocrine system. Endocr. Rev. 1992, 13, 719-764.
3. Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M. et al., The role of vitamin D in cancer prevention. Am. J. Public Health 2006, 96, 252-261.
4. Garland, C. F., Gorham, E. D., Mohr, S. B., Grant, W. B. et al., Vitamin D and prevention of breast cancer: pooled analysis. J. Steroid Biochem. Mol. Biol. 2007, 103, 708-711.
5. Gorham, E. D., Garland, C. F., Garland, F. C., Grant, W. B. et al., Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am. J. Prev. Med. 2007, 32, 210-216.
6. Holick, M. F., Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
7. Gupta, D., Lammersfeld, C. A., Trukova, K., Lis, C. G., Vitamin D and prostate cancer risk: a review of the epidemiological literature. Prostate Cancer Prostatic Dis. 2009, 12, 215-226.
8. Hypponen, E., Laara, E., Reunanen, A., Jarvelin, M. R. et al., Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358, 1500-1503.
9. Mathieu, C., Gysemans, C., Giulietti, A., Bouillon, R., Vitamin D and diabetes. Diabetologia 2005, 48, 1247-1257.
10. Pittas, A. G., Dawson-Hughes, B., Li, T., Van Dam, R. M. et al., Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29, 650-656.
11. Forman, J. P., Curhan, G. C., Taylor, E. N., Plasma 25- hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008, 52, 828-832.
12. Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S. et al., Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. J. Am. Med. Assoc. 2006, 296, 2832-2838.
13. Ascherio, A., Munger, K., Epidemiology of multiple sclerosis: from risk factors to prevention. Semin. Neurol. 2008, 28, 17-28.
14. Cantorna, M. T., Vitamin D and multiple sclerosis: an update. Nutr. Rev. 2008, 66, S135-S138.
15. Newton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y. M. et al., Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J. Clin. Oncol. 2009, 27, 5439-5444.
16. Bikle, D. D., Vitamin D and the immune system: role in protection against bacterial infection. Curr. Opin. Nephrol. Hypertens. 2008, 17, 348-352.
17. Cannell, J. J., Zasloff, M., Garland, C. F., Scragg, R. et al., On the epidemiology of influenza. Virol. J. 2008, 5, 29.
18. Ginde, A. A., Liu, M. C., Camargo, C. A., Jr., Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch. Intern. Med. 2009, 169, 626-632.
19. Kuchuk, N. O., Pluijm, S. M., van Schoor, N. M., Looman, C. W. et al., Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J. Clin. Endocrinol. Metab. 2009, 94, 1244-1250.
20. Munns, C., Zacharin, M. R., Rodda, C. P., Batch, J. A. et al., Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Med. J. Aust. 2006, 185, 268-272.
21. Looker, A. C., Pfeiffer, C. M., Lacher, D. A., Schleicher, R. L. et al., Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am. J. Clin. Nutr. 2008, 88, 1519-1527.
22. Working Group of the Australian and New Zealand Bone and Mineral Society. Endocrine society of Australia and osteoporosis Australia, vitamin D and adult bone health in Australia and New Zealand: a position statement. Med. J. Aust. 2005, 182, 281-285.
23. Qaseem, A., Snow, V., Shekelle, P., Hopkins, R., Jr. et al., Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 2008, 149, 404-415.
24. Trang, H. M., Cole, D. E. C., Rubin, L. A., Pierratos, A. et al., Evidence that vitamin D-3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D-2. Am. J. Clin. Nutr. 1998, 68, 854-858.
25. Brown, E. M., Pollak, M., Seidman, C. E., Seidman, J. G. et al., Seminars in medicine of the Beth-Israel-Hospital, Boston - calcium-ion-sensing cell-surface receptors. N. Engl. J. Med. 1995, 333, 234-240.
26. Kiela, P. R., Ghishan, F. K., Recent advances in the renalskeletal- gut axis that controls phosphate homeostasis. Lab. Invest. 2009, 89, 7-14.
27. Razzaque, M. S., Sitara, D., Taguchi, T., St-Arnaud, R. et al., Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 2006, 20, 720-722.
28. Bhalla, A. K., Amento, E. P., Clemens, T. L., Holick, M. F., et al., Specific high-affinity receptors for 1,25-dihydroxyvitamin- D3 in human peripheral-blood mononuclear-cells - presence in monocytes and induction in lymphocytes-T following activation. J. Clin. Endocrinol. Metab. 1983, 57, 1308-1310.
29. Lee, S., Clark, S. A., Gill, R. K., Christakos, S., 1,25-Dihydroxyvitamin- D(3) and pancreatic beta-cell function - vitamin- D receptors, gene-expression, and insulin-secretion. Endocrinology 1994, 134, 1602-1610.
30. Bischoff-Ferrari, H. A., Giovannucci, E., Willett, W. C., Dietrich, T. et al., Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 2006, 84, 18-28.
31. Holick, M. F., Vitamin D: a millenium perspective. J. Cell. Biochem. 2003, 88, 296-307.
32. Holick, M. F., Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 2004, 79, 362-371.
33. Hart, G. R., Furniss, J. L., Laurie, D., Durham, S. K., Measurement of vitamin D status: background, clinical use, and methodologies. Clin. Lab. 2006, 52, 335-343.
34. Barragry, J. M., France, M. W., Corless, D., Gupta, S. P. et al., Intestinal cholecalciferol absorption in the elderly and in younger adults. Clin. Sci. Mol. Med. 1978, 55, 213-220.
35. Clemens, T. L., Zhou, X. Y., Myles, M., Endres, D. et al., Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J. Clin. Endocrinol. Metab. 1986, 63, 656-660.
36. Seamans, K. M., Cashman, K. D., Existing and potentially novel functional markers of vitamin D status: a systematic review. Am. J. Clin. Nutr. 2009, 89, 1997S-2008S.
37. Chapuy, M. C., Preziosi, P., Maamer, M., Arnaud, S. et al., Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 1997, 7, 439-443.
38. Grant, W. B., Holick, M. F., Benefits and requirements of vitamin D for optimal health: a review. Altern. Med. Rev. 2005, 10, 94-111.
39. Heaney, R. P., The vitamin D requirement in health and disease. J. Steroid Biochem. Mol. Biol. 2005, 97, 13-19.
40. Vieth, R., Bischoff-Ferrari, H., Boucher, B. J., Dawson-Hughes, B. et al., The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 2007, 85, 649-650.
41. Holick, M. F., Vitamin D status: measurement, interpretation, and clinical application. Ann. Epidemiol. 2009, 19, 73-78.
42. Carter, G. D., Carter, C. R., Gunter, E., Jones, J. et al., Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 467-471.
43. Aloia, J. F., African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am. J. Clin. Nutr. 2008, 88, 545S-550S.
44. Maetani, M., Maskarinec, G., Franke, A. A., Cooney, R. V., Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr. Cancer 2009, 61, 225-231.
45. Harrison, S. L., Nowak, M., Buettner, P. G., Kimlin, M. G. et al., Public health and clinical dilemmas resulting from imprecise vitamin D tests. J. Rural Trop. Public Health 2009, 8, 52-58.
46. Haddad, J. G., Chyu, K. J., Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J. Clin. Endocrinol. Metab. 1971, 33, 992-995.
47. Hollis, B. W., Burton, J. H., Draper, H. H., A binding assay for 25-hydroxycalciferols and 24R,25-dihydroxycalciferols using bovine plasma globulin. Steroids 1977, 30, 285-293.
48. Belsey, R. E., DeLuca, H. F., Potts, J. T., Jr., A rapid assay for 25-OH-vitamin D3 without preparative chromatography. J. Clin. Endocrinol. Metab. 1974, 38, 1046-1051.
49. Dorantes, L. M., Arnaud, S. B., Arnaud, C. D., Kilgust, K. A., Importance of isolation of 25-hydroxyvitamin-D before assay. J. Lab. Clin. Med. 1978, 91, 791-796.
50. Hollis, B. W., Napoli, J. L., Improved radioimmunoassay for vitamin-D and its use in assessing vitamin-D status. Clin. Chem. 1985, 31, 1815-1819.
51. Hollis, B. W., Kamerud, J. Q., Selvaag, S. R., Lorenz, J. D. et al., Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin. Chem. 1993, 39, 529-533.
52. Carter, G. D., Jones, J. C., Berry, J. L., The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays. J. Steroid Biochem. Mol. Biol. 2007, 103, 480-482.
53. Hollis, B. W., Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin. Chem. 2000, 46, 1657-1661.
54. Carter, G. D., 25-Hydroxyvitamin D assays: the quest for accuracy. Clin. Chem. 2009, 55, 1300-1302.
55. Kimball, S. M., Vieth, R., A comparison of automated methods for the quantitation of serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Clin. Biochem. 2007, 40, 1305-1310.
56. Ersfeld, D. L., Rao, D. S., Body, J. J., Sackrison, J. L., Jr. et al., Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin. Biochem. 2004, 37, 867-874.
57. Souberbielle, J. C., Fayol, V., Sault, C., Lawson-Body, E. et al., Assay-specific decision limits for two new automated parathyroid hormone and 25-hydroxyvitamin D assays. Clin. Chem. 2005, 51, 395-400.
58. Binkley, N., Krueger, D., Lensmeyer, G., 25-Hydroxyvitamin D measurement, 2009: a review for clinicians. J. Clin. Densitom. 2009, 12, 417-427.
59. Carter, G. D., Carter, R., Jones, J., Berry, J., How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin. Chem. 2004, 50, 2195-2197.
60. Terry, A. H., Sandrock, T., Meikle, A. W., Measurement of 25-hydroxyvitamin D by the Nichols ADVANTAGE, DiaSorin LIAISON, DiaSorin RIA, and liquid chromatography-tandem mass spectrometry. Clin. Chem. 2005, 51, 1565-1566.
61. Glendenning, P., Taranto, M., Noble, J. M., Musk, A. A. et al., Current assays overestimate 25-hydroxyvitamin D-3 and underestimate 25-hydroxyvitamin D-2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann. Clin. Biochem. 2006, 43, 23-30.
62. Leino, A., Turpeinen, U., Koskinen, P., Automated measurement of 25-OH vitamin D3 on the Roche Modular E170 analyzer. Clin. Chem. 2008, 54, 2059-2062.
63. Eisman, J. A., Shepard, R. M., DeLuca, H. F., Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. Anal. Biochem. 1977, 80, 298-305.
64. Maunsell, Z., Wright, D. J., Rainbow, S. J., Routine isotopedilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D-2 and D-3. Clin. Chem. 2005, 51, 1683-1690.
65. Lensmeyer, G. L., Wiebe, D. A., Binkley, N., Drezner, M. K., HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin. Chem. 2006, 52, 1120-1126.
66. Zerwekh, J. E., Blood biomarkers of vitamin D status. Am. J. Clin. Nutr. 2008, 87, 1087S-1091S.
67. Hollis, B. W., Horst, R. L., The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going. J. Steroid Biochem. Mol. Biol. 2007, 103, 473-476.
68. Carter, G. D., Jones, J. C., Use of a common standard improves the performance of liquid chromatographytandem mass spectrometry methods for serum 25-hydroxyvitamin- D. Ann. Clin. Biochem. 2009, 46, 79-81.
69. Pollack, A., The New York Times, New York 2009, p. B1, January 8.
70. Coldwell, R. D., Trafford, D. J., Varley, M. J., Makin, H. L. et al., The measurement of vitamins D2 and D3 and seven major metabolites in a single sample of human plasma using gas chromatography/mass spectrometry. Biomed. Environ. Mass Spectrom. 1988, 16, 81-85.
71. Carter, G. D., Nolan, J., Trafford, D. J. H., Makin, H. L. J., in: Norman, A. W., Bouillon, R., Thomasset, M. (Eds.), Vitamin D: Chemistry, Biology and Clinical Applications of the Seroid Hormone, University of California, Riverside 1997, pp. 737-738.
72. Hollis, B. W., Kamerud, J. Q., Kurkowski, A., Beaulieu, J. et al., Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clin. Chem. 1996, 42, 586-592.
73. Brumbaugh, P. F., Haussler, D. H., Bressler, R., Haussler, M. R., Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3. Science 1974, 183, 1089-1091.
74. Clemens, T. L., Hendy, G. N., Graham, R. F., Baggiolini, E. G. et al., Radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin. Sci. Mol. Med. 1978, 54, 329-332.
75. Binkley, N., Krueger, D., Cowgill, C. S., Plum, L. et al., Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J. Clin. Endocrinol. Metab. 2004, 89, 3152-3157.
76. Vitamin D External Quality Assessment Scheme (DEQAS). 25 Hydroxyvitamin D October 2009 Distribution, 2009.
77. Lips, P., Chapuy, M. C., Dawson-Hughes, B., Pols, H. A. P. et al., An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos. Int. 1999, 9, 394-397.
78. Singh, R. J., Taylor, R. L., Reddy, G. S., Grebe, S. K., C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J. Clin. Endocrinol. Metab. 2006, 91, 3055-3061.
79. Glendenning, P., Issues of standardization and assayspecific clinical decision limits for the measurement of 25- hydroxyvitamin D. Am. J. Clin. Nutr. 2003, 77, 522-523.
80. Glendenning, P., Fraser, W. D., 25-OH-vitamin D assays. J. Clin. Endocrinol. Metab. 2005, 90, 3129.
81. Phinney, K. W., Development of a standard reference material for vitamin D in serum. Am. J. Clin. Nutr. 2008, 88, 511S-512S.
82. Roth, H. J., Schmidt-Gayk, H., Weber, H., Niederau, C., Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatographytandem mass spectrometry as a reference. Ann. Clin. Biochem. 2008, 45, 153-159.
83. Cavalier, E., Rozet, E., Gadisseur, R., Carlisi, A. et al., Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos. Int. 2009, DOI 10.1007/s00198-009-1052-5.
84. McNally, J. D., Matheson, L. A., Sankaran, K., Rosenberg, A. M., Capillary blood sampling as an alternative to venipuncture in the assessment of serum 25 hydroxyvitamin D levels. J. Steroid Biochem. Mol. Biol. 2008, 112, 164-168.
85. Eyles, D., Anderson, C., Ko, P., Jones, A. et al., A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin. Chim. Acta 2009, 403, 145-151.
86. Lucas, R. M., Ponsonby, A. L., Pasco, J. A., Morley, R., Future health implications of prenatal and early-life vitamin D status. Nutr. Rev. 2008, 66, 710-720.
87. Fairney, A., Saphier, P. W., Studies on the measurement of 25-hydroxy vitamin D in human saliva. Br. J. Nutr. 1987, 57, 13-25.
88. Higashi, T., Shibayama, Y., Fuji, M., Shimada, K., Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status. Anal. Bioanal. Chem. 2008, 391, 229-238.
89. Hunter, D., De Lange, M., Snieder, H., MacGregor, A. J. et al., Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J. Bone Miner. Res. 2001, 16, 371-378.
90. Orton, S. M., Morris, A. P., Herrera, B. M., Ramagopalan, S. V. et al., Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am. J. Clin. Nutr. 2008, 88, 441-447.
91. Torkildsen, O., Knappskog, P. M., Nyland, H. I., Myhr, K. M., Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Arch. Neurol. 2008, 65, 809-811.
92. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009, 41, 824-828.
93. Bailey, R., Cooper, J. D., Zeitels, L., Smyth, D. J. et al., Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007, 56, 2616-2621.
94. Daiger, S. P., Schanfield, M. S., Cavalli-Sforza, L. L., Groupspecific component (Gc) proteins bind vitamin D and 25- hydroxyvitamin D. Proc. Natl. Acad. Sci. USA 1975, 72, 2076-2080.
95. Lauridsen, A. L., Vestergaard, P., Hermann, A. P., Brot, C. et al., Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 - early postmenopausal women. Calcif. Tissue Int. 2005, 77, 15-22.
96. Kawakami, M., Blum, C. B., Ramakrishnan, R., Dell, R. B. et al., Turnover of the plasma-binding protein for vitamin-D and its metabolites in normal human-subjects. J. Clin. Endocrinol. Metab. 1981, 53, 1110-1116.